Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00847626 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension
A Phase 3 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,711
- Enrollment target
NCT00847626: Completed Phase 3 study, sponsored by Takeda.
NCT00847626 is a Phase 3 study that has completed, run by Takeda. The registered enrollment target is 1,711 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (122% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00847626, a Phase 3 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,711 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy and safety of azilsartan medoxomil combined with chlorthalidone, once daily (QD), in participants with moderate to severe hypertension.
Primary Outcome
The change in trough systolic blood pressure measured at final visit or week 8 relative to baseline. Ambulatory blood pressure monitoring measures blood pressure at regular intervals throughout the day and night. The trough is the average of all measurements recorded from 22 to 24 hours after dosing.
Interventions
- DRUG Azilsartan medoxomil and chlorthalidone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,711 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-07 |
| Phase | Phase 3 |
What the finished NCT00847626 record still lists
NCT00847626 is an interventional study that assigns participants to a tested intervention. Its 1,711 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (122% higher).
The record links to 0 conditions, and to 1 intervention - of which Azilsartan medoxomil and chlorthalidone is the first listed.
NCT00847626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00847626 about?
NCT00847626 is a clinical study titled "Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension". The purpose of this study is to determine the efficacy and safety of azilsartan medoxomil combined with chlorthalidone, once daily (QD), in participants with moderate to severe hypertension.
What is the current status of trial NCT00847626?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,711 participants. The study started on 2009-01. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00847626?
The interventions under investigation include: Azilsartan medoxomil and chlorthalidone (DRUG).
Who is sponsoring clinical trial NCT00847626?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00847626's enrollment target sits among peer trials
1,711 132nd of 2000 higher than 1,869 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05303636 · 1,710 participants · Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia